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Absence of Serological Evidence of West Nile Virus in Blood Donors in South 
Western Nigeria 
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ABSTRACT  
Background: West Nile virus (WNV) is a mosquito-borne virus that circulates among avians, but can also 
affect other species, particularly humans and horses. The virus is transmissible via blood transfusion.  
Objectives: To determine the prevalence of the West Nile virus among blood donors in Nigeria.  
Materials and Methods: Serum samples from 185 blood donors who donated blood at blood bank units of 
Obafemi Awolowo University Teaching hospitals and Ladoke Akintola University Teaching Hospital, 
Nigeria were screened for WNV IgM antibody.  
Results: Out of the 185 donors recruited for the study, 175 (94.6%) were males. The age of the participant 
ranges from 18 – 65 years with the mean age (SD± 20.3). One hundred and sixty five (89.1%) donors are 
urban dwellers while twenty (10.8%) donors are rural dwellers. Twenty seven donors (15.4%), out of the 
urban group regularly use insecticides treated or mosquito repellant nets whereas none of the rural dwellers 
use insecticides or mosquito net. All the 185 donors screened were negative for West Nile virus- specific 
IgM antibody.  
Conclusion: This study reveals that there is no serological evidence of WNV infection in Osun state Nigeria. 
Although this is only a preliminary report, there would be the need for a more elaborate study cutting across 
different seasons of the year on the prevalence of WNV in Nigeria.  
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est Nile virus (WNV) is a mosquito-
borne zoonotic arbovirus belonging 
to the Flaviviridae family in the 
genus flavivirus1.  The virus belongs to the 
Japanese encephalitis virus complex or 
serogroup. This flavivirus is found in 
temperate and tropical regions of the world. It 
was first isolated in 1937 in Northern Uganda 
in a region close to a tributary of the river 
Nile, is widely distributed in Africa, Asia, the 
Middle East and Europe 2. West Nile Virus 
disease occurred only sporadically and was 
considered a minor risk for humans, until an 
outbreak in Algeria in 1994, with cases of 
WNV-caused encephalitis and the first large 
outbreak in Romania in 1996, with a high 
number of cases with neuroinvasive disease. 
The WNV was isolated from patients, birds 
and mosquitoes in1950 in Egypt 3. In a survey  
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for WNV haemagglutination-inhibition (HI) 
antibody carried    out   in   Nigeria    fourteen    
years agoa prevalence of WNV 
haemagglutination-inhibition (HI) antibody of 
40% was reported 4.  In a more recent study in 
suspected febrile malaria and typhoid patients 
a prevalence of 25% for WNV neutralizing 
antibody was reported 5. 
The main mode of West Nile (WNV) 
transmission is through mosquito bites. Aedes 
egypti and various species of mosquitoes, are 
the prime vectors of the virus with the birds 
being the most commonly affected animal and 
serving as the prime reservoir host. Only 
female mosquitoes feed on blood and 
different species are involved to take a blood 
meal on preferred types of vertebrate hosts.  
Infections have been documented in ticks in 
Asia, Europe and the Middle East, and soft 
(argasid) ticks have been shown to transmit 
WNV in the laboratory. Hippoboscid flies 
might be able to transmit this virus in North 
America and infected lice (Philopterus spp.) 6.  
Transmissions through blood transfusion, 
organ transplantation, and breast-feeding have 
also been reported 7. Human illness by WNV 
can be classified into two forms: West Nile 
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fever, which is relatively mild and flu-like, 
and West Nile neuroinvasive disease, which 
encompasses all cases with neurological 
signs. Many WNV infections are 
asymptomatic 7. 
West Nile fever is the most common form of 
the disease. Most uncomplicated infections 
resolve in 2 to 6 days, but in some severe 
cases, persistent fatigue can last for a month 
or more8. 
A few patients with West Nile fever develop 
West Nile neuroinvasive disease. This form 
can be severe, and in some cases, it is life-
threatening 9 .Three syndromes - encephalitis, 
meningitis, and acute flaccid paralysis – are 
seen. Symptoms of more than one syndrome 
often occur in the same patient. West Nile 
meningitis is characterized by fever, 
headache, a stiff neck and photophobia 10. 
Patients with West Nile encephalitis have 
changes in consciousness, disorientation and, 
or focal neurological signs, which may 
include ataxia, incoordination, tremors, 
involuntary movements, and signs that 
resemble Parkinson’s disease (rigidity, 
postural instability and bradykinesia). 
Concurrent signs of meningitis are common, 
and seizures or coma may also occur. Some 
patients who recover have persistent 
neurological dysfunction. 11 
Acute flaccid paralysis (sometimes called 
West Nile poliomyelitis) is seen in some 
patients. The paralysis, which resembles 
polio, appears suddenly and progresses 
rapidly, usually reaching a plateau within 
hours. It is typically asymmetrical and can 
affect one or more limbs, often the legs. The 
weakened limbs become darker than normal 
at the peak of the paralysis. This syndrome 
may be accompanied by muscle aches in the 
lower back and or abnormalities in bladder 
and bowel function. Some patients develop 
respiratory distress, which may require 
mechanical ventilation. Sensory functions are 
usually normal or minimally affected. Some 
patients with flaccid paralysis have prodromal 
signs of West Nile fever, sometimes with 
signs of meningitis or encephalitis; however, 
many patients are asymptomatic before the 
onset of paralysis. Late in the illness, the 
muscles may become atrophied. Recovery is 
highly variable: some patients recover 
completely within weeks, while others remain 
paralyzed12.  
West Nile virus can also be transmitted by 
transfusion through infected blood 
components. In the United States (US), WNV 
transmission to humans was detected in 1999 
during an outbreak of encephalitis in New 
York City and it was first detected among 
blood donors in 200213. As a result, WNV 
nucleic acid testing (NAT) among blood 
donors began in 2003 at the blood transfusion 
unit 14.  
In Africa particularly Nigeria, there is scarcity 
of information about the prevalence of the 
virus among blood donors. This study was 
therefore undertaken to investigate the 
seroprevalence of WNV in a population of 
healthy blood donors living in southwestern 
Nigeria in order to determine whether this 
emerging infection is a possible risk for the 
blood supply in Nigeria.  
 
MATERIALS AND METHODS: 
Study population: 
Healthy blood donors attending the Ladoke 
Akintola University Teaching hospital blood 
bank in Ogbomoso and Obafemi Awolowo 
University Teaching Ile Ife, southwestern 
Nigeria between May and October 2013 were 
recruited into this study. Informed consent 
was sought from the donors and only those 
who consented were included in the study. 
Questionnaires were used to obtain 
demographic information as well as 
information on the use of insecticide net, 
records of immunization, knowledge on West 
Nile virus infection and educational status. 
Serological Test  
Five milliliters of venous blood was collected 
from the antecubital vein of each donor. The 
blood was allowed to retract and then 
centrifuged at 1500 rpm. The sera were stored 
at -20°C until tested. HBsAg and HCV 
antibody were detected in each serum sample 
by means of an immuno-chromatographic 
mini strip (HBsAg DiaSpot One Step and 
HCV DiaSpot One Step, USA) and HIV 
antibody were detected by means of an 
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immuno-chromatographic test strip (Alere 
Determine HIV1/2 Matsuhidal, Japan). West 
Nile IgM antibody was detected by enzyme 
linked immunoassay method (ELISA) (Wkea 
Med. Supp., Changchun, Chenguang Garden, 
Qianjin, China)  
RESULTS: 
A total of one hundred and eighty five (185) 
donors were recruited for the study of which 
175 (94.6%) were males. The age of the 
participants ranges from 18 to 65 with a mean 
age of 41.5.  
Out of the 185 donors, 2 (1.08%) tested 
positive for HIV-1 and HIV-2. Eleven (5.9%) 
were positive for Hepatitis B virus, and only 
1(0.5%) was positive for HCV antibody. 
However none of the 185 donors was positive 
for the WNV IgM antibody.  
From the questionnaire survey and the 
interviews, only 90 (48.6%) have a record of 
immunization with yellow fever virus out of 
which 87 (97%) were males. None of the 
respondent had a previous knowledge of West 
Nile virus infection.  
Twenty (10.8%) were rural dwellers (i.e. 
those who have no access to tertiary health 
facilities and basic amenities such as 
electricity good roads e.tc) while One 
hundred and sixty five (89.1%) were urban 
dwellers. Only 27(15.4%) out of the urban 
group regularly use insecticides or mosquito 
repellant net whereas none of the rural 
dwellers use insecticides or mosquito 
repellant net. Only 5% out of the urban 
dwellers group use insecticides and mosquito 
repellant.  
DISCUSSION: 
West Nile virus is a known cause of flu-like 
illness and neuroinvasive diseases (such as 
meningitis, acute flaccid paralysis etc). Due to 
the outbreak of the virus in 1999 from cases 
of encaphilitis in United States 14 and 
established evidence of its transmission in 
blood transfusion, screening of blood donors 
for WNV was instituted in July, 2005 15.  
The pattern of transmission of WNV and 
incidence of cases reported among the 
infected subject vary due to temperatures, 
rainfall, regional seasonal differences and bird 
migratory form 16. These stated factors are 
determined by a climatic change and also 
influence the outbreak of infection, with 
higher arbovirus infection in the rainy 
season17. The findings of this study are 
similar to a previous study in Nigeria where 
the investigators reported a low endemicity of 
WNV during the dry season18. The result of 
this study might not be not unrelated to the 
weather situation at the period during which 
the study was conducted as the study was 
conducted in the dry season, supporting the 
report of Baba et al16. 
Out of 185 serum samples collected for this 
study, none was positive for IgM anti-WNV 
antibodies; this indicates that there was no 
recent exposure to the virus among the blood 
donors in the southwestern part of Nigeria. 
However, we had a limitation in this study of 
accessing the WNV IgG antibody in the 
donors screened, as this would have given a 
picture of their previous exposure to the virus. 
Although, oftentimes the specificity of the 
IgG antibodies is always low because it cross 
react with other members of the Flaviviruses 
such as Dengue virus, Yellow virus. Though a 
good number of the respondents did not use 
insecticide treated nets this however seems 
not to affect the prevalence of the WNV IgM 
antibodies in them. 
West Nile virus is an emerging disease with 
still a low prevalence among blood donors. 
Similar to the findings of this study is a study 
in Iranian which equally showed absence of 
WNV IgM in blood donors 19. In a study in 
2004, the presence of WNV RNA in Dutch 
blood donor samples was investigated but 
WNV infection was not observed among 
these Dutch blood donors 20.  
CONCLUSION: 
There is no serological evidence of acute 
WNV infection observed among the blood 
donors in this study. The West Nile infection 
can be said to have faded into obscurity in 
southwestern Nigeria, however due to the 
complexity in the transmission of WNV and 
increase in re-emergence rate of previously 
neglected diseases, it is very important that 
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blood banks and transfusion unit should give 
serious attention to any manifestation of 
symptoms associated with WNV in the 
donors. Proper questioning, screening and 
correct examination of the blood donors is 
very necessary to ensure safe blood 
transfusion. Also, effective preventive 
measure to avoid contact with the vector 
(mainly the specific mosquitoes) should be 
encouraged through the use of insecticide 
treated nets and history of travel to endemic 
areas is highly important to minimize the risk 
of WNV transmission. However, in order to 
increase the safety of blood donation, it is 
essential to maintain a sustained surveillance 
for this re-emerging infection in order to 
protect the blood supply in the future.  
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